ANDOSAN

Serial Number 79364782
Registration 7383414
700

Registration Progress

Application Filed
Feb 17, 2023
Under Examination
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered
May 14, 2024

Trademark Image

ANDOSAN

Basic Information

Serial Number
79364782
Registration Number
7383414
Filing Date
February 17, 2023
Registration Date
May 14, 2024
Published for Opposition
February 27, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 14, 2024
Registration
Registered
Classes
005

Rights Holder

Mycotech Pharma AS

99
Address
Lilleakerveien 2B
N-0283 OSLO
NO

Ownership History

Mycotech Pharma AS

Original Applicant
99
NO

Mycotech Pharma AS

Owner at Publication
99
NO

Mycotech Pharma AS

Original Registrant
99
NO

Legal Representation

Attorney
Christian D. Abel

USPTO Deadlines

Next Deadline
1596 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20240514)
Due Date
May 14, 2030
Grace Period Ends
November 14, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Sep 26, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 30, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 8, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 8, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 14, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 14, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 14, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 18, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 19, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 29, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Nov 29, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 28, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 27, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 14, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 10, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 9, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary and nutritional supplements; health food supplements for humans; nutraceuticals for use as dietary supplements

Classification

International Classes
005